This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

DMPA-SC Access Collaborative Brief

Subcutaneous DMPA (DMPA-SC, brand name Sayana Press) is an innovative injectable contraceptive that can dramatically expand access and choice for women. Led by PATH and John Snow Inc., the DMPA-SC Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit the DMPA-SC Access Collaborative page or email FPoptions@path.org.

Publication date: October 2019

Available materials

  1. English

    1. Subcutaneous DMPA Access Collaborative brief 182.3 KB PDF

  2. French

    1. Le Collaboratif pour l’accès au DMPA sous-cutané 195.2 KB PDF